MD Anderson study shows FGL2 protein may be an effective target for glioblastoma

IMAGE: This is Shulin Li, Ph.D. view more  Credit: MD Anderson Cancer Center HOUSTON – Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma (GBM) progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation. Findings from the preclinical study led…

‘Why can’t a woman be more like a man?’ studying gender’s role in Alzheimer’s disease

IMAGE: This is Roberta Diaz Brinton, Ph.D. view more  Credit: University of Arizona Health Sciences TUCSON, Ariz. – Alzheimer’s disease hits women harder than men. Nearly two-thirds of Americans who have Alzheimer’s are women, and more than 60 percent of Alzheimer’s and dementia caregivers are women, according to the Alzheimer’s Association. Worldwide, 47 million people are…

Cancer patients can quit smoking through lengthened medication time, counseling support

CHICAGO — Quitting smoking can significantly improve the effectiveness of cancer treatment, according to the U.S. Surgeon General, yet almost half of cancer patients continue to smoke after they’ve been diagnosed. A new study from Northwestern Medicine and the Abramson Cancer Center at the University of Pennsylvania found cancer patients have better success quitting and are not…

Penn’s ‘enhanced recovery’ protocol reduces opioid use in spinal surgery patients

PHILADELPHIA – A novel “Enhanced Recovery After Surgery” (ERAS) protocol developed by Penn Medicine for patients undergoing spinal and peripheral nerve surgery significantly reduced opioid use. A new study published in the Journal of Neurosurgery: Spine showed that when an ERAS protocol was employed–which optimizes patients’ surgical care before, during, and after surgery, including patient…

Gero to reveal its latest results in aging research at Longevity Therapeutics 2019

Gero is a data-driven longevity company developing innovative therapies that will strongly extend the healthy period of life also known as healthspan. Latest results of Gero aging studies will be presented at Longevity Therapeutics Conference in San Francisco, January 29-31, 2019. Peter Fedichev, founder and Chief Scientific Officer of Gero, will open “Supporting Discovery in…